279 related articles for article (PubMed ID: 16085680)
1. Mechanisms of homocysteine-induced oxidative stress.
Tyagi N; Sedoris KC; Steed M; Ovechkin AV; Moshal KS; Tyagi SC
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2649-56. PubMed ID: 16085680
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine.
Lee SJ; Kim KM; Namkoong S; Kim CK; Kang YC; Lee H; Ha KS; Han JA; Chung HT; Kwon YG; Kim YM
J Biol Chem; 2005 Feb; 280(7):5781-8. PubMed ID: 15561702
[TBL] [Abstract][Full Text] [Related]
3. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
Tyagi N; Gillespie W; Vacek JC; Sen U; Tyagi SC; Lominadze D
J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
[TBL] [Abstract][Full Text] [Related]
4. [The pathogenic mechanism of homocysteine -induced endothelial nitric oxide synthase dysfunction and the antagonistic effects by folic acid].
Zhang JG; Wang LZ; Han XQ; Jiang YD; Zhang RM; Wang SR
Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Feb; 40(1):17-23. PubMed ID: 17357445
[TBL] [Abstract][Full Text] [Related]
5. Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity.
Tyagi N; Moshal KS; Sen U; Lominadze D; Ovechkin AV; Tyagi SC
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):21-7. PubMed ID: 17543202
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
Selley ML
J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
[TBL] [Abstract][Full Text] [Related]
7. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
Jia F; Wu C; Chen Z; Lu G
Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia.
Tyagi N; Ovechkin AV; Lominadze D; Moshal KS; Tyagi SC
J Cell Biochem; 2006 Aug; 98(5):1150-62. PubMed ID: 16514665
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species mediates homocysteine-induced mitochondrial biogenesis in human endothelial cells: modulation by antioxidants.
Perez-de-Arce K; Foncea R; Leighton F
Biochem Biophys Res Commun; 2005 Dec; 338(2):1103-9. PubMed ID: 16259958
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
Jin L; Caldwell RB; Li-Masters T; Caldwell RW
J Physiol Pharmacol; 2007 Jun; 58(2):191-206. PubMed ID: 17622691
[TBL] [Abstract][Full Text] [Related]
11. GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia.
Shastry S; Moning L; Tyagi N; Steed M; Tyagi SC
J Cell Physiol; 2005 Dec; 205(3):422-7. PubMed ID: 15895389
[TBL] [Abstract][Full Text] [Related]
12. Effects of homocysteine on endothelial nitric oxide production.
Zhang X; Li H; Jin H; Ebin Z; Brodsky S; Goligorsky MS
Am J Physiol Renal Physiol; 2000 Oct; 279(4):F671-8. PubMed ID: 10997917
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene.
Zhang JG; Liu JX; Li ZH; Wang LZ; Jiang YD; Wang SR
Chin Med J (Engl); 2007 Dec; 120(23):2132-7. PubMed ID: 18167189
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase.
Scalera F; Kielstein JT; Martens-Lobenhoffer J; Postel SC; Täger M; Bode-Böger SM
J Am Soc Nephrol; 2005 Apr; 16(4):892-8. PubMed ID: 15728783
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.
Stühlinger MC; Tsao PS; Her JH; Kimoto M; Balint RF; Cooke JP
Circulation; 2001 Nov; 104(21):2569-75. PubMed ID: 11714652
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
[TBL] [Abstract][Full Text] [Related]
17. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
19. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of NADPH oxidase and JNK in homocysteine-induced oxidative stress and apoptosis in human umbilical vein endothelial cells.
Dong F; Zhang X; Li SY; Zhang Z; Ren Q; Culver B; Ren J
Cardiovasc Toxicol; 2005; 5(1):9-20. PubMed ID: 15738581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
